123 related articles for article (PubMed ID: 16332952)
1. Disease-modifying anti-rheumatic drugs are only one of a number of potential causes of myelosuppression: a careful drug history is necessary to elucidate the cause of an adverse event.
Marshall RW; Marshall VJ; Hull R
Rheumatology (Oxford); 2006 Mar; 45(3):362-3; author reply 363-4. PubMed ID: 16332952
[No Abstract] [Full Text] [Related]
2. [A case of pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis and trimethoprim-sulphamethoxazole induced pancytopenia].
Shimada T; Nishimura Y; Funada Y; Takenaka K; Kobayashi K; Urata Y; Yosimura S; Nishiuma T; Satouchi M; Yokoyama M
Arerugi; 2004 Jun; 53(6):575-81. PubMed ID: 15247519
[TBL] [Abstract][Full Text] [Related]
3. [Serious adverse effects of methotrexate therapy in patients with rheumatic arthritis].
Purokivi M; Myllykangas-Luosujärvi R; Jantunen E
Duodecim; 1998; 114(21):2187-90. PubMed ID: 11757107
[No Abstract] [Full Text] [Related]
4. Methotrexate induced pancytopenia is rare and concern for it should not limit its use.
Yazici Y
Rheumatology (Oxford); 2006 Mar; 45(3):361; author reply 363-4. PubMed ID: 16332954
[No Abstract] [Full Text] [Related]
5. Methotrexate-induced pancytopenia associated with co-prescription of penicillin and trimethoprim.
Sathi N; Dawson J
Clin Rheumatol; 2007 Jan; 26(1):134-5. PubMed ID: 16941195
[No Abstract] [Full Text] [Related]
6. Methotrexate induced neutropenia associated with coprescription of penicillins: serious and under-reported?
Sathi N; Ackah J; Dawson J
Rheumatology (Oxford); 2006 Mar; 45(3):361-2; author reply 363-4. PubMed ID: 16332953
[No Abstract] [Full Text] [Related]
7. Pancytopenia and severe cytopenia induced by low-dose methotrexate. Eight case-reports and a review of one hundred cases from the literature (with twenty-four deaths).
Berthelot JM; Maugars Y; Hamidou M; Chiffoleau A; Barrier J; Grolleau JY; Prost A
Rev Rhum Engl Ed; 1995; 62(7-8):477-86. PubMed ID: 8574610
[TBL] [Abstract][Full Text] [Related]
8. Coadministration of lansoprazole and naproxen does not affect the pharmacokinetic profile of methotrexate in adult patients with rheumatoid arthritis.
Vakily M; Amer F; Kukulka MJ; Andhivarothai N
J Clin Pharmacol; 2005 Oct; 45(10):1179-86. PubMed ID: 16172183
[TBL] [Abstract][Full Text] [Related]
9. [Pancytopenia during low-dosage methotrexate treatment in patients with rheumatoid arthritis].
Nygaard H
Tidsskr Nor Laegeforen; 1993 Sep; 113(22):2805-7. PubMed ID: 8211900
[TBL] [Abstract][Full Text] [Related]
10. Cotton wool spots as an indicator of methotrexate-induced blood dyscrasia.
Klemencic S
Optometry; 2010 Apr; 81(4):177-80. PubMed ID: 20346888
[TBL] [Abstract][Full Text] [Related]
11. [Pancytopenia during treatment of rheumatoid arthritis with methotrexate after administration of trimethoprim-sulfamethoxazole].
Thevenet JP; Ristori JM; Cure H; Mizony MH; Bussiere JL
Presse Med; 1987 Sep; 16(30):1487. PubMed ID: 2957686
[No Abstract] [Full Text] [Related]
12. Pancytopenia associated with leflunomide and methotrexate.
Hill RL; Topliss DJ; Purcell PM
Ann Pharmacother; 2003 Jan; 37(1):149. PubMed ID: 12503951
[No Abstract] [Full Text] [Related]
13. Comment: severe pancytopenia associated with methotrexate therapy for rheumatoid arthritis.
Mofredj A; Baraka D; Charoud A
Ann Pharmacother; 2002; 36(7-8):1295. PubMed ID: 12086573
[No Abstract] [Full Text] [Related]
14. Fatal pancytopenia in a hemodialysis patient after treatment with low-dose methotrexate.
Cheung KK; Chow KM; Szeto CC; Tai MH; Kwan BC; Li PK
J Clin Rheumatol; 2009 Jun; 15(4):177-80. PubMed ID: 19502905
[TBL] [Abstract][Full Text] [Related]
15. [Megaloblastic pancytopenia in a female patient with rheumatoid arthritis given methotrexate and amidopyrine simultaneously].
Noskov SM
Ter Arkh; 1990; 62(9):122-3. PubMed ID: 2281394
[TBL] [Abstract][Full Text] [Related]
16. Serious pancytopenia from methotrexate treatment of psoriatic arthritis.
Chang YC; Chen JD; Yen DH; Wang LM; Huang CI; Lee CH
Am J Emerg Med; 2006 May; 24(3):392-4. PubMed ID: 16635735
[No Abstract] [Full Text] [Related]
17. DMARDS and infections in rheumatoid arthritis.
Caporali R; Caprioli M; Bobbio-Pallavicini F; Montecucco C
Autoimmun Rev; 2008 Dec; 8(2):139-43. PubMed ID: 19014871
[TBL] [Abstract][Full Text] [Related]
18. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
19. Fatal Cytopenia Induced by Low-Dose Methotrexate in Elderly With Rheumatoid Arthritis. Identification of Risk Factors.
Mameli A; Barcellona D; Marongiu F
Am J Ther; 2017; 24(1):e106-e107. PubMed ID: 27574942
[No Abstract] [Full Text] [Related]
20. Incidence of pancytopenia with methotrexate treatment of rheumatoid arthritis in Germany: comment on the article by Gutierrez-Ureña et al.
Kassai A; Rautenstrauch H
Arthritis Rheum; 1997 Jan; 40(1):195-6. PubMed ID: 9008621
[No Abstract] [Full Text] [Related]
[Next] [New Search]
